证券代码：603276 证券简称：恒兴新材 公告编号：2025-071 江苏恒兴新材料科技股份有限公司 关于重新论证后继续使用募集资金实施部分募投项目、终止 实施部分募投项目及变更募集资金用途的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 原项目名称：原项目一"山东衡兴二期工程（8.45 万吨）"、原项目二 "年产 10 万吨有机酸及衍生产品项目" 新项目名称及投资金额：新项目一"10 万吨/年多碳醛醇酯等产品项目"， 投资总额预计为 28,000.00 万元；新项目二"研发及营销中心建设项目"，投资 总额预计为 3,000.00 万元 变更募集资金投向的金额：变更 23,772.80 万元募集资金用途投向新项目 一，变更 3,000.00 万元募集资金用途投向新项目二。经充分论证、谨慎研究，江 苏恒兴新材料科技股份有限公司（以下简称"公司"）拟对"山东衡兴二期工程 （8.45 万吨）"和"年产 10 万吨有机酸及衍生产品项目"中的部分项目继续实 施或终止实施，除预留继续使用募集资金投入实施的募投项目所 ...

证券代码：603276 证券简称：恒兴新材 公告编号：2025-073 江苏恒兴新材料科技股份有限公司 关于召开2025年第二次临时股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025 年 10 月 14 日 10 点 00 分 召开地点：宜兴市青墩路 1 号 (五)网络投票的系统、起止日期和投票时间。 二、 会议审议事项 股东大会召开日期：2025年10月14日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 (一)股东大会类型和届次 2025年第二次临时股东大会 (二)股东大会召集人：董事会 (三)投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结合的 方式 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 10 月 14 日 至2025 年 10 月 14 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当 ...

证券代码：603276 证券简称：恒兴新材 公告编号：2025-070 江苏恒兴新材料科技股份有限公司 第二届监事会第十九次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 江苏恒兴新材料科技股份有限公司（以下简称"公司"）第二届监事会第十 九次会议于 2025 年 9 月 18 日以现场结合通讯方式召开。会议通知已于 2025 年 9 月 12 日通过书面文件的方式送达各位监事。本次会议应出席监事 3 人，实际 出席监事 3 人。 会议由监事会主席姚云松先生主持。本次会议的召集、召开和表决程序符合 有关法律、法规、规范性文件和《公司章程》的规定。出席会议的监事对各项议 案进行了认真审议并做出了如下决议： 二、监事会会议审议情况 （一）审议通过《关于重新论证后继续使用募集资金实施部分募投项目、 终止实施部分募投项目及变更募集资金用途的议案》 监事会认为，本次公司重新论证后继续使用募集资金实施部分募投项目、终 止实施部分募投项目及变更募集资金用途，能够提高募集资金使用效率，是结合 公司业务发展 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 江苏恒兴新材料科技股份有限公司（以下简称"公司"）第二届董事会第二 十四次会议于 2025 年 9 月 18 日以现场结合通讯方式召开。会议通知已于 2025 年 9 月 12 日通过书面文件的方式送达各位董事。本次会议应参加表决的董事 7 人，实际参加表决的董事 7 人。 会议由董事长张千先生主持。本次会议的召集、召开和表决程序符合有关法 律、法规、规范性文件和《公司章程》的规定。经各位董事认真审议，会议形成 了如下决议： 二、董事会会议审议情况 （一）审议通过《关于重新论证后继续使用募集资金实施部分募投项目、 终止实施部分募投项目及变更募集资金用途的议案》 证券代码：603276 证券简称：恒兴新材 公告编号：2025-069 江苏恒兴新材料科技股份有限公司 第二届董事会第二十四次会议决议公告 表决结果：7 票同意；0 票反对；0 票弃权。 （二）审议通过《关于使用募集资金向全资子公司增资或借款以实施募投 项目的议案》 1 董事会同意在本次公司完成终止 ...

格隆汇9月18日丨恒兴新材(603276.SH)上公布，公司使用自有资金3,726.38万元、募集资金14,591.26万 元形成的对全资子公司宁夏港兴新材料科技有限公司(以下简称"宁夏港兴")的债权，对宁夏港兴增资， 增资金额全部计入资本公积;同意公司使用募集资金5,486.96万元形成的对全资子公司山东衡兴新材料科 技有限公司(以下简称"山东衡兴")的债权，对山东衡兴增资，增资金额全部计入资本公积。本次公司完 成终止使用募集资金实施部分项目并变更募集资金用途的审议后，同意公司累计使用募集资金中的 40,744.41万元、26,255.59万元一次或分次分别向公司全资子公司宁夏港兴、山东衡兴以增资或借款的形 式实施募投项目。 ...

Core Viewpoint - Hengxing New Materials reported that as of September 10, 2025, the number of shareholders is 12,233 [2] Company Summary - Hengxing New Materials has a total of 12,233 shareholders as of the specified date [2]

Core Viewpoint - Jiangsu Hengxing New Material Technology Co., Ltd. held a half-year performance briefing on September 9, 2025, to discuss its operational results and financial status for the first half of 2025 with investors [2][3]. Meeting Overview - The company announced the performance briefing on August 27, 2025, and collected questions from investors in advance through the Shanghai Stock Exchange's official website and email [3]. - The briefing featured key executives, including the Chairman, General Manager, and Financial Director, who engaged with investors on various topics within the scope of information disclosure [3]. Key Investor Questions and Responses - **Asset-Liability Ratio**: The company aims to maintain a low asset-liability ratio through refined operations and supply chain optimization, ensuring financial stability and safety [4]. - **Fragrance Products Development**: The company is actively developing around 20 new fragrance products, leveraging market trends and its technical capabilities to drive growth in this sector [4]. - **Strategic Planning for H2 2025**: The company will continue to focus on integrated and series strategies, emphasizing technological innovation and market expansion [5]. - **Product Advantages**: The company highlights its integrated production model, technical research and development capabilities, and strong market presence as key competitive advantages [6]. - **R&D Innovations**: In the first half of 2025, the company made significant advancements in R&D, focusing on high-end specialty chemicals and successfully investing in silicon-based materials [7].

证券代码：603276 证券简称：恒兴新材 公告编号：2025-068 江苏恒兴新材料科技股份有限公司 关于 2025 年半年度业绩说明会召开情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 江苏恒兴新材料科技股份有限公司（以下简称"公司"）于 2025 年 9 月 9 日（星期二）下午 13:00-14:00，通过上海证券交易所上证路演中心（网址： http://roadshow.sseinfo.com/）以网络互动方式召开了"江苏恒兴新材料科技股份有 限公司关于 2025 年半年度业绩说明会"，就公司 2025 年半年度经营成果、财务 状况等与广大投资者进行了互动交流和沟通。 一、本次业绩说明会的召开情况 公司于 2025 年 8 月 27 日通过上海证券交易所官网（http://www.sse.com.cn） 披露了《关于召开 2025 年半年度业绩说明会的公告》（公告编号：2025-065）， 并 通 过 上 证 路 演 中 心 网 站 首 页 " 提 问 预 征 集 " 栏 目 （ ht ...

Group 1 - The core point of the article is that Hengxing New Materials has experienced a decline in the number of shareholders for the second consecutive period, indicating a potential shift in investor sentiment [2] - As of August 31, the number of shareholders decreased to 12,369, a reduction of 671 shareholders, representing a 5.15% decline compared to the previous period [2] - The closing price of Hengxing New Materials on the reporting date was 18.27 yuan, down 4.14%, although the stock price has increased by 6.72% since the concentration of shares began [2] Group 2 - The latest margin trading data shows that as of September 1, the total margin balance for the stock was 144 million yuan, with a slight increase of 32,100 yuan, or 0.02% [2] - The company's semi-annual report indicates that it achieved operating revenue of 392 million yuan in the first half of the year, reflecting a year-on-year growth of 9.99% [2] - The net profit for the same period was 29.1151 million yuan, which represents a year-on-year decline of 8.53%, with basic earnings per share at 0.1400 yuan and a weighted average return on equity of 1.68% [2]

Core Viewpoint - The document outlines the fundraising management system of Zhejiang Zhongxin Environmental Protection Technology Group Co., Ltd, emphasizing the importance of regulating the use and management of raised funds to protect investors' interests [1]. Fundraising Management - The company must establish internal control systems for the storage, use, and management of raised funds, ensuring clear regulations on storage, usage, changes, supervision, and accountability [1][2]. - The board of directors and senior management are responsible for ensuring the proper use of raised funds and must not participate in any unauthorized changes to the fund's purpose [2][3]. Fund Storage - Raised funds must be stored in a special account approved by the board of directors, and this account should not be used for non-fund purposes [7]. - A tripartite supervision agreement must be signed with the sponsor and the commercial bank within one month of the funds being received, detailing the management and oversight of the funds [8][9]. Fund Usage - The company must adhere to specific requirements when using raised funds, including clear application procedures, decision-making processes, and risk control measures [9][10]. - Funds should primarily be used for the company's main business, and any financial investments or loans to related parties are prohibited [10][11]. Idle Funds Management - Idle funds can be temporarily used for cash management, provided that the investments are safe and do not affect the normal investment plans [11][12]. - If idle funds are used to supplement working capital, it must be reported and approved by the board, and the funds must be returned to the special account within a specified timeframe [12][13]. Use of Excess Funds - Any excess funds raised beyond the planned amount must be allocated to ongoing or new projects, or for share buybacks, with a clear plan disclosed by the company [13][14]. - The use of excess funds requires board approval and must be disclosed to shareholders, ensuring transparency and accountability [14]. Fund Usage Change - Any changes to the use of raised funds must be approved by the board and the shareholders, with a clear explanation provided for the changes [18][19]. - The company must conduct feasibility analyses for new projects and ensure that they align with the main business objectives [19][20]. Fund Management and Supervision - The company is required to disclose the actual use of raised funds accurately and completely [23]. - The board must conduct semi-annual reviews of the fundraising projects and report on the status of fund usage [24][25]. Compliance and Reporting - Independent directors and the audit committee must monitor the management and usage of raised funds, and can engage external auditors for verification [25][26]. - The sponsor must conduct regular investigations into the management of raised funds and provide reports to the company and the stock exchange [26][27].